VSA vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

VSA

38.7
AI Score
VS
UTI Wins

UTI

47.3
AI Score

Investment Advisor Scores

VSA

39score
Recommendation
SELL

UTI

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VSA UTI Winner
Revenue 160.41M 835.62M UTI
Net Income -80.43M 63.02M UTI
Net Margin -50.1% 7.5% UTI
Operating Income -69.37M 83.47M UTI
ROE 32.6% 19.2% VSA
ROA -583.5% 7.6% UTI
Total Assets 13.79M 826.14M UTI
Cash 6.62M 127.36M UTI
Current Ratio 0.03 1.07 UTI

Relative Price Performance (Last 90 Days)

VSA 1M: -3.6% · 3M: +962.9% UTI 1M: -42.2% · 3M: -38.9%

Current Technical Phase

VSA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.1 · Price: $3.50

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $22.35

Fundamentals Snapshot

Metric VSA UTI
Market Cap
Forward P/E 23.5 30.4
Trailing P/E 39.5
Revenue (TTM)
Revenue Growth -0.8% 0.1%
Gross Margin 0.2% 0.6%
Operating Margin -18.3% 0.0%
EPS -76.53 0.58
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.